Trial intelligence / Profile preview

Acetazolamide for IOP rise in Trendelenburg position

NCT03107429Completed

Sponsor
University of Nottingham
Start
Mar 2015
Primary completion
Oct 2015
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in ocular hypertension comparing Acetazolamide Sequence with Placebo Sequence (2 arms). Primary endpoint: Change in Intraocular Pressure. Started Mar 2015; status: completed.

02

Drugs

acetazolamide
03

Conditions

ocular hypertension

Beyond the preview

Go deeper on NCT03107429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03107429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call